Form 8-K - Current report:
SEC Accession No. 0001104659-21-100407
Filing Date
2021-08-05
Accepted
2021-08-05 07:05:20
Documents
12
Period of Report
2021-08-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2124113d1_8k.htm   iXBRL 8-K 52202
  Complete submission text file 0001104659-21-100407.txt   227557

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zyne-20210803.xsd EX-101.SCH 3185
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyne-20210803_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyne-20210803_pre.xml EX-101.PRE 22710
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2124113d1_8k_htm.xml XML 3621
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 211146252
SIC: 2834 Pharmaceutical Preparations